Current developments in the pharmacology of neuromuscular blocking agents indicate that within the next several years, nondepolarizing drugs of short and intermediate duration of action, devoid of significant side effects, may become a reality. The important factors which may permit their development are reviewed.
No takes yet. Share an insight, caveat, or question.
Savarese et al. (1974) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: